Some stocks have rebounded far more than expected while others appear to be getting back into gear.
Stemline Therapeutics, Entercom Communications and Ocular Therapeutix offer reasons to think their shares will perform better in the New Year.
Shares of Stemline Therapeutics and Entercom Communications headed opposite directions last Friday after reporting results.
Stemline Therapeutics and Entercom Communications seem to have stabilized after notable declines late in the summer.
Let's look at the charts of SIRI and SPOT.
An owner of radio stations, a homebuilder and a wellness company still offer value even after the broader market's run to record highs.
Insider purchases have tapered off from their frenzied pace in late 2018, but here are three names where such buying is evident.
Entercom Communications, W.R. Grace, Newmark Group and a few airlines are seeing insider purchases.
Since Foot Locker's earnings weren't as bad as people thought, TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer said there's a resurgence with Nike and Under Armour isn't that far behind.
The two small-cap names appear undervalued at current trading levels.